Quality of life (II). Quality of life in dermatology;Calidad de vida (II). Calidad de vida en dermatología

Actas Dermo-Sifiliograficas

Volumn 93, Issue 8, 2002, Pages 481-489

  Jones Caballero, María ^a,b   Peñas, Pablo F ^b  

^a Ayuntamiento de Madrid   (Spain)

^b HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

Author keywords

Dermatology; Quality of life

Indexed keywords

EID: 0038893701     PISSN: 00017310     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0001-7310(02)76619-2     Document Type: Article

References (115)

1. Layton AM. Psychological assessment of skin disease. Interfaces Dermatol 1994;1:9-11.
2. Shuster S, Fisher GH, Harris E, Binnell D. The effect of skin disease on self image. Br J Dermatol 1978;99:18-9.
3. Finlay AY. Measures of the effect of adult severe atopic eczema on quality of life. J Eur Acad Dermatol Venereol 1996;7:149-54.
4. Finlay AY, Coles EC. The effect of severe psoriasis on the quality of life of 369 patients. Br J Dermatol 1995;132:236-44.
5. Finlay AY, Khan GK, Luscombe DK, Salek MS. Validation of sickness impact profile and psoriasis disability index in psoriasis. Br J Dermatol 1990;123:751-6.
6. O'Donnell BF, Lawlor F, Simpson J, Morgan M, Greaves MW. Chronic urticaria: impact on quality of life. Br J Dermatol 1995;133(Suppl 45):27.
7. Mallon E, Newton JN, Klassen A, Stewart-Brown SL, Ryan TJ, Finlay AY. The quality of life in acne: a comparison with general medical conditions using generic questionnaires. Br J Dermatol 1999;140:672-6.
8. Rapp SR, Feldman SR, Exum ML, Fleischer AB, Reboussin DM. Psoriasis causes as much disability as other major medical diseases. J Am Acad Dermatol 1999;41:401-7.
9. Gupta MA, Gupta AK. Psoriasis and sex: a study of moderately to severely affected patients. Int J Dermatol 1997; 36:259-62.
10. Jowett S, Ryan R. Skin disease and handicap: an analysis of the impact of skin conditions. Soc Sci Med 1985;20:425-9.
11. O'Neill P, Kelly P. Postal questionnaire study of disability in the community associated with psoriasis. BMJ 1996;313: 919-21.
12. Phillips T, Stanton B, Provan A, Lew R. A study of the impact of leg ulcers on quality of life: financial, social, and psychologic implications. J Am Acad Dermatol 1994;31:49-53.
13. Cunliffe WJ. Acne and unemployment. Br J Dermatol 1986;115:386.
14. Cunliffe WJ. Valoración psicológica. En: Dunitz M, editor. Nuevos conceptos en el tratamiento de la acné. Londres: Martin Dunitz; 1994. p. 15-22.
15. McKenna KE, Stern RS. The impact of psoriasis on the quality of life of patients from 16-center PUVA follow-up cohort. J Am Acad Dermatol 1997;36:388-94.
16. Gupta MA, Schork NJ, Gupta AK, Kirkby S, Ellis CN. Suicidal ideation in psoriasis. Int J Dermatol 1993;32:188-90.
17. Denicoff KD, Lehman ZA, Rubinow DR, Schmidt PJ, Peck GL. Suicidal ideation in Darier's disease. J Am Acad Dermatol 1990;22:196-8.
18. Lawson V, Lewis-Jones MS, Finlay AY, Reid P, Owens RG. The family impact of childhood atopic dermatitis: the dermatitis family impact questionnaire. Br J Dermatol 1998; 138:107-13.
19. Lundberg L, Johannesson M, Silverdahl M, Hermansson C, Lindberg M. Quality of life, health-state utilities and willingness to pay in patients with psoriasis and atopic eczema. Br J Dermatol 1999;141:1067-75.
20. Finlay AY. Quality of life measurement in dermatology: a practical guide. Br J Dermatol 1997;136:305-14.
21. Guyatt GH, Feeny DH, Patrick DL. Measuring health-related quality of life. Ann Intern Med 1993;118:622-9.
22. Girman CJ, Hartmaier S, Thiboutot D, Johnson J, Barber B, De Muro-Mercon C, et al. Evaluating health-related quality of life in patients with facial acne: development of a self-administered questionnaire for clinical trials. Qual Life Res 1996;5:481-90.
23. Lasek RJ, Chren MM. Acne vulgaris and the quality of life of adult dermatology patients. Arch Dermatol 1998;134: 454-8.
24. Klassen AF, Newton JN, Mallon K. Measuring quality of life in people referred for specialist care of acne: comparing generic and disease-specific measures. J Am Acad Dermatol 2000;43:229-33.
25. Newton JN, Mallon E, Klassen A, Ryan TJ, Finlay AY. The effectiveness of acne treatment: an assessment by patients of the outcome of therapy. Br J Dermatol 1997;137:563-7.
26. Grosshans E, Marks R, Mascaro JM, Torras H, Meynadier J, Alirezai M, et al. Evaluation of clinical efficacy and safety of adapalene 0.1% gel versus tretinoin 0.025% gel in the treatment of acne vulgaris, with particular reference to the onset of action and impact on quality of life. Br J Dermatol 1998;139(Suppl 52):26-33.
27. Williamson D, González M, Finlay AY. The effect of hair loss on quality of life. J Eur Acad Dermatol Venereol 2001;15:137-9.
28. Blackford S, Finlay AY, Roberts DL. Quality of life in Behcet's syndrome: 335 patients surveyed. Br J Dermatol 1997; 136:293.
29. Blackford S, Roberts D, Salek MS, Finlay A. Basal cell carcinomas cause little handicap. Qual Life Res 1996;5:191-4.
30. Harris A, Burge SM, Dykes PJ, Finlay AY. Handicap in Darier's disease and Hailey-Hailey disease. Br J Dermatol 1996;135:959-63.
31. Linnet J, Jemec GB. An assessment of anxiety and dermatology life quality in patients with atopic dermatitis. Br J Dermatol 1999;140:268-72.
32. Drake L, Prendergast M, Maher R, Breneman D, Korman N, Saloi Y, et al. The impact of tacrolimus ointment on health-related quality of life of adult and pediatric patients with atopic dermatitis. J Am Acad Dermatol 2001;44:S65-72.
33. Holness DL. Results of a quality of life questionnaire in a patch test clinic population. Contact Dermatitis 2001;44: 80-4.
34. Hutchings CV, Shum KW, Gawkrodger DJ. Occupational contact dermatitis has an appreciable impact on quality of life. Contact Dermatitis 2001;45:17-20.
35. Taboulet F, Halioua B, Malkin JE. Quality of life and use of health care among people with genital herpes in France. Acta Derm Venereol 1999;79:380-4.
36. Mauskopf JA, Austin R, Dix LP, Berzon RA. Estimating the value of a generic quality-of-life measure. Med Care 1995; 33:AS195-202.
37. Von der Werth JM, Jemec GB. Morbidity in patients with hidradenitis suppurativa. Br J Dermatol 2001;144:809-13.
38. Swan MC, Paes T. Quality of life evaluation following endoscopic transthoracic sympathectomy for upper limb and facial hyperhydrosis. Ann Chir Gynaecol 2001;90:157-9.
39. Swartling C, Naver H, Lindberg M. Botulinum A toxin improves life quality in severe primary focal hyperhidrosis. Eur J Neurol 2001;8:247-52.
40. Kurwa HA, Finlay AY. Dermatology in-patient management greatly improves life quality. Br J Dermatol 1995;133:575-8.
41. Hurwitz D, Kerdel FA, Kirsner RS. Hospitalization for skin disease improves quality of life. Arch Dermatol 1997;133: 797-8.
42. Vensel E, Hilley T, Trent J, Taylor JR, Kinsner RS, Kerdel FA, et al. Sustained improvement of quality of life of patients with psoriasis after hospitalization. J Am Acad Dermatol 2000;43:858-60.
43. Sigurdardóttir V, Bolund C, Brandberg Y, Sullivan M. The impact of generalized malignant melanoma on quality of life evaluated by the EORTC questionnaire technique. Qual Life Res 1993;2:193-203.
44. Wolkenstein P, Zeller J, Revuz J, Ecosse E, Leplege A. Quality-of-life impairment in neurofibromatosis type 1: a cross-sectional study of 128 cases. Arch Dermatol 2001;137: 1421-5.
45. Jobanputra R, Bachmann M. The effect of skin diseases on quality of life in patients from different social and ethnic groups in cape town, south africa. Int J Dermatol 2000; 39:826-31.
46. Nichol MB, Margolies JE, Lippa E, Rowe M, Quell J. The application of multiple quality-of-life instruments in individuals with mild-to-moderate psoriasis. Pharmacoeconomics 1996;10:644-53.
47. Wahl A, Loge JH, Wiklund I, Hanestad BR. The burden of psoriasis: a study concerning health-related quality of life among Norwegian adult patients with psoriasis compared with general population norms. J Am Acad Dermatol 2000;43:803-8.
48. Touw CR, Hakkaart-Van Roijen L, Verboom P, Paul C, Rutten FF, Finlay AY. Quality of life and clinical outcome in psoriasis patients using intermittent cyclosporin. Br J Dermatol 2001;144:967-72.
49. Harlow D, Poyner T, Finlay AY, Dykes PJ. Impaired quality of life of adults with skin disease in primary care. Br J Dermatol 2000;143:979-82.
50. Rajagopalan R, Anderson R. Impact of patch testing on dermatology-specific quality of life in patients with allergic contact dermatitis. Am J Contact Dermat 1997;8: 215-21.
51. Lindholm C, Bjellerup M, Christensen OB, Zederfeldt B. Quality of life in chronic leg ulcer patients. An assessment according to the Nottingham Health Profile. Acta Derm Venereol 1993;73:440-3.
52. Poon E, Seed PT, Greaves MW, Kobza-Black A. The extent and nature of disability in different urticarial conditions. Br J Dermatol 1999;140:667-71.
53. Thompson AK, Finn AF, Schoenwetter WF. Effect of 60 mg twice-daily fexofenadine HCl on quality of life, work and classroom productivity, and regular activity in patients with chronic idiopathic urticaria. J Am Acad Dermatol 2000; 43:24-30.
54. Kent G, Al-Abadie M. Psychologic effects of vitiligo: a critical incident analysis. J Am Acad Dermatol 1996;35:895-8.
55. Kent G, Al-Abadie M. Factors affecting responses on Dermatology Life Quality Index items among vitiligo sufferers. Clin Exp Dermatol 1996;21:330-3.
56. Njoo MD, Bos JD, Westerhof W. Treatment of generalized vitiligo in children with narrow-band (TL-01) UVB radiation therapy. J Am Acad Dermatol 2000;42:245-53.
57. Van der Donk J, Hunfeld JA, Passchier J, Knegt-Junk KJ, Nieboer C. Quality of life and maladjustment associated with hair loss in women with alopecia androgenetica. Soc Sci Med 1994;38:159-63.
58. Girman CJ, Hartmaier S, Roberts J, Bergfeld W, Waldstreicher J. Patient-perceived importance of negative effects of androgenetic alopecia in women. J Womens Health Gend Based Med 1999;8:1091-5.
59. Hunt SM, Alonso J, Bucquet D, Niero M, Wiklund I, McKenna S. Cross-cultural adaptation of health measures. Health Policy 1991;19:33-44.
60. Badía X, Alonso J. Adaptación de una medida de la disfunción relacionada con la enfermedad: la versión española del Sickness Impact Profile. Med Clin (Barc) 1994; 102:90-5.
61. Alonso J, Prieto L, Antó JM. The Spanish version of the Nottingham Health Profile: a review of adaptation and instrument characteristics. Qual Life Res 1994;3:385-93.
62. Escalante A, Galarza-Delgado D, Beardmore TD, Baethge BA, Esquivel-Valerio J, Marines AL, et al. Cross-cultural adaptation of a brief outcome questionnaire for Spanish-speaking arthritis patients. Arthritis Rheum 1996;39:93-100.
63. Ferrer M, Alonso J, Prieto L, Plaza V, Monso E, Marrades R, et al. Validity and reliability of the St George's Respiratory Questionnaire after adaptation to a different language and culture: the Spanish example. Eur Respir J 1996;9:1160-6.
64. Agra Y, Badía X. Spanish version of the Rotterdam Symptom Check List: cross-cultural adaptation and preliminary validity in a sample of terminal cancer patients. Psychooncology 1998;7:229-39.
65. Lichtenstein MJ, Hazuda HP. Cross-cultural adaptation of the hearing handicap inventory for the Elderly-Screening Version (HHIE-S) for use with Spanish-speaking Mexican Americans. J Am Geriatr Soc 1998;46:492-8.
66. Guell R, Casan P, Sangenis M, Morante F, Belda J, Guyatt GH. Quality of life in patients with chronic respiratory disease: the Spanish version of the Chronic Respiratory Questionnaire (CRQ). Eur Respir J 1998;11:55-60.
67. García de Tiedra A, Mercadal J, Badía X, Mascaró JM, Lozano R. A method to select an instrument for measurement of HR-QOL for cross-cultural adaptation applied to Dermatology. Pharmacoenomics 1998;14:405-22.
68. García de Tiedra A, Mercadal J, Badía X, Mascaró JM, Herdman M, Lozano R. Adapración transcultural al español del cuestionario Dermatology Life Quality Index (DLQI): el índice de calidad de vida en Dermatología. Actas Dermosifiliogr 1998;89:692-700.
69. Badía X, Mascaró JM, Lozano R. Measuring health-related quality of life in patients with mild to moderate eczema and psoriasis: clinical validity, reliability and sensitivity to change of the DLQI. The Cavide Research Group. Br J Dermatol 1999;141:698-702.
70. Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI): a simple practical measure for routine clinical use. Clin Exp Dermatol 1994;19:210-6.
71. Jones-Caballero M, Peñas PF, García-Díez A, Badía X, Chren MM. The Spanish version of Skindex-29. Int J Dermatol 2000;39:907-912.
72. Jones-Caballero M, Penas PF, García-Díez A, Chren MM, Badía X. La versión española de Skindex-29. Un instrumento de medida de la calidad de vida en pacienes con enfermedades cutáneas. Med Clin (Barc) 2002;118:5-9.
73. Guillemin F, Bombardier C, Beaton D. Cross-cultural adaptation of health-related quality of life measures: literature review and proposed guidelines. J Clin Epidemiol 1993; 46:1417-32.
74. Hendrichson WD, Russell IJ, Prihoda TJ, Jacobson JM, Rogan A, Bishop GD. An approach to developing a valid spanish language translatation of a health-status questionnaire. Medical Care 1989;27:959-66.
75. a ed. Barcelona: Edimac; 1999.
76. Chren MM, Lasek RJ, Quinn LM, Nostow EN, Zyzanski SJ. Skindex, a quality-of-life measure for patients with skin disease: reliability, validity, and responsiveness. J Invest Dermatol 1996;107:703-13.
77. Chren MM, Lasek RJ, Flocke SA, Zyzanski SJ. Improved discriminative and evaluative capability of a refined version of Skindex, a quality-of-life instrument for patients with skin diseases. Arch Dermatol 1997;133:1433-40.
78. Chren MM, Lasek RJ, Quinn LM, Covinsky KE. Convergent and discriminant validity of a generic and a disease-specific instrument to measure quality of life in patients with skin disease. J Invest Dermatol 1997;108:103-7.
79. Picardi A, Abeni D, Melchi CF, Puddu P, Pasquini P. Psychiatric morbidity in dermatological outpatients: an issue to be recognized. Br J Dermatol 2000;143:983-91.
80. Lohr KN, Aaronson NK, Alonso J, et al. Evaluating quality-of-life and health status instruments: development of scientific review criteria. Clin Therap 1996;18:979-92.
81. Chren MM, Lasek RJ, Sahay AP, Sands LP. Measurement properties of Skindex-16: a brief quality-of-life measure for patients with skin diseases. J Cutan Med Surg 2001;5:105-10.
82. Salek MS. Measuring the quality of life of patients with skin diseases. En: Walker SR, Rosser RM, editores. Quality of life assessment; key issues in the 1990s. Lancaster: Kluwer Academic; 1993. p. 355-70.
83. Ryan TJ. The confident nude or whither dermatology. Dermatol Pract 1987;5:8-18.
84. Lisi P, Stingeni L, Benvenuti C, Rantuccio F, Vena GA, Tosti A, et al. Quaviderm: un questionario per la valutazione della qualità di vita italiana in dermatologia. Ann Ital Dermatol Clin Sper 1997;51:39-44.
85. Schmid-Ott G, Jaeger B, Kuensebeck HW, Ott R, Lamprecht F. Dimensions of stigmatization in patients with psoriasis in a «Questionnaire on Experience with Skin Complaints». Dermatology 1996;193:304-10.
86. Schmid-Ott G, Kuensebeck HW, Jaeger B, Werfel T, Frahm K, Ruitman J, et al. Validity study for the stigmatization experience in atopic dermatitis and psoriatic patients. Acta Derm Venereol 1999;79:443-7.
87. Wessely SC, Lewis GH. The classification of psychiatric morbidity in attenders at a dermatology clinic. Br J Psychiatry 1989;155:686-91.
88. Morgan M, McCreedy R, Simpson J, Hay RJ. Dermatology quality of life scales-a measure of the impact of skin diseases. Br J Dermatol 1997;136:202-6.
89. Lewis-Jones MS, Finlay AY. The Children's Dermatology Life Quality Index (CDLQI): initial validation and practical use. Br J Dermatol 1995;132:942-9.
90. Anderson RT, Rajagopalan R. Development and validation of a quality of life instrument for cutaneous diseases. J Am Acad Dermatol 1997;37:41-50.
91. Rauch PK, Jellinek MS, Murphy JM, Schachner L, Hansen R, Esterly NB, et al. Screening for psychosocial dysfunction in pediatric dermatology practice. Clin Pediatr 1991; 30:493-7.
92. Grob JJ, Auquier P, Martin S, Lancon C, Bonerandi JJ. Development and validation of a quality of life measurement for chronic skin disorders in french: VQ-Dermato. Dermatology 1999;199:213-22.
93. Augustin M, Zschocke I, Lange S, Seidenglanz K, Amon U. Lebensqualität bie Hauterkrankungen: Vergleich verschiedener Lebensqualitäts-Fragebögen bei Psoriasis und atopischer Dermatitis. Hautarzt 1999;50:715-22.
94. Martin AR, Lookingbill DP, Botek A, Light J, Thiboutot D, Girman CJ. Health-related quality of life among patients with facial acne-assessment of a new acne-specific questionnaire. Clin Exp Dermatol 2001;26: 380-5.
95. Gupta MA, Johnson AM, Gupta AK. The development of an Acne Quality of Life scale: reliability, validity, and relation to subjective acne severity in mild to moderate acne vulgaris. Acta Derm Venereol 1998;78:451-6.
96. Motley RJ, Finlay AY. How much disability is caused by acne? Clin Exp Dermatol 1989;14:194-8.
97. Motley RJ, Finlay AY. Practical use of a disability index in routine management of acne. Clin Exp Dermatol 1992;17:1-3.
98. Schmidt S, Fischer TW, Chren MM, Strauss BM, Elsner P. Strategies of coping and quality of life in women with alopecia. Br J Dermatol 2001;144:1038-43.
99. Salek MS, Finlay AY, Luscombe DK, Allen BR, Berth-Jones J, Camp RD, et al. Cyclosporin greatly improves the quality of life of adults with severe atopic dermatitis. A ramdomized, double-blind, placebo-controlled trial. Br J Dermatol 1993;129:422-30.
100. Wild D, Patrick D, Johnson E, Berzon R, Wald A. Measuring health-related quality of life in persons with genital herpes. Qual Life Res 1995;4:532-9.
101. Aftergut K, Carmody T, Cruz PD, Jr. Use of the HIV-DERMDEX quality-of-life instrument in HIV-infected patients with skin disease. Int J Dermatol 2001;40:478-81.
102. Lubeck DP, Patrick DL, McNulty P, Fifer SK, Birnbaum J. Quality of life of persons with onychomycosis. Qual Life Res 1993;2:341-8.
103. Lubeck DP. Measuring health-related quality of life in onychomycosis. J Am Acad Dermatol 1998;38:S64-8.
104. Drake LA, Patrick DL, Fleckman P, Andr J, Baran R, Haneke E, et al. The impact of onychomycosis on quality of life: development of an international onychomycosis-specific questionnaire to measure patient quality of life. J Am Acad Dermatol 1999;41:189-96.
105. Fleischer AB J, Clark AR, Rapp SR, Reboussin DM, Feldman SR. Commercial tanning bed treatment is an effective psoriasis treatment: results from an uncontrolled clinical trial. J Invest Dermatol 1997;109: 170-4.
106. Finlay AY, Kelly SE. Psoriasis-an index of disability. Clin Exp Dermatol 1987;12:8-11.
107. Kent G, Al-Abadie M. The psoriasis disability index, further analyses. Clin Exp Dermatol 1993;18:414-6.
108. Fortune DG, Main CJ, O'Sullivan TM, Griffiths CE. Quality of life in patients with psoriasis; the contribution of clinical variables and psoriasis-specific stress. Br J Dermatol 1997;137:755-60.
109. Kirby B, Fortune DG, Bhushan M, Chalmers RJ, Griffiths CE. The Salford Psoriasis Index: an holistic measure of psoriasis severity. Br J Dermatol 2000;142:728-32.
110. Gupta MA, Gupta AK. The psoriasis life stress inventory: a preliminary index of psoriasis-related stress. Acta Derm Venereol 1995;75:240-3.
111. Blades B, Mellis N, Munster AM. A burn specific health scale. J Trauma 1982;22:872-5.
112. Salvador Sanz JF, Sánchez-Paya J, Rodríguez Marín J. Spanish version of the Burn-Specific Health Scale. J Trauma 1998;45:581-7.
113. Tilkorn M, Mawick R, Sommerfeld S, Strittmauer G. Quality of life of patients with malignant facial and skin tumors- development of a questionnaire and initial findings of a study (resumen). Rehabilitation (Stuttg) 1990; 29:134-9.
114. Kurz X, Lamping DL, Kahn SR, Baccaglini U, Zuccarelli F, Spreafico G, et al. Do varicose veins affect quality of life? Results of an international population-based study. J Vasc Surg 2001;34:641-8.
115. Hyland ME, Ley A, Thomson B. Quality of life of leg ulcers. J Wound Care 1994;3:294-8.